4.8 Article

MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search

期刊

NUCLEIC ACIDS RESEARCH
卷 45, 期 D1, 页码 D877-D887

出版社

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkw1012

关键词

-

资金

  1. Weizmann Institute of Science
  2. LifeMap Sciences Inc., CA, USA
  3. Crown Human Genome Center at the Weizmann Institute of Science

向作者/读者索取更多资源

The MalaCards human disease database (http://www.malacards.org/) is an integrated compendium of annotated diseases mined from 68 data sources. MalaCards has a web card for each of similar to 20 000 disease entries, in six global categories. It portrays a broad array of annotation topics in 15 sections, including Summaries, Symptoms, Anatomical Context, Drugs, Genetic Tests, Variations and Publications. The Aliases and Classifications section reflects an algorithm for disease name integration across often-conflicting sources, providing effective annotation consolidation. A central feature is a balanced Genes section, with scores reflecting the strength of disease-gene associations. This is accompanied by other gene-related disease information such as pathways, mouse phenotypes and GO-terms, stemming from MalaCards' affiliation with the GeneCards Suite of databases. MalaCards' capacity to inter-link information from complementary sources, along with its elaborate search function, relational database infrastructure and convenient data dumps, allows it to tackle its rich disease annotation landscape, and facilitates systems analyses and genome sequence interpretation. MalaCards adopts a `flat' disease-card approach, but each card is mapped to popular hierarchical ontologies (e.g.International Classification of Diseases, Human Phenotype Ontology and Unified Medical Language System) and also contains information about multi-level relations among diseases, thereby providing an optimal tool for disease representation and scrutiny.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据